Trial intelligence / Profile preview

One-year study of tranexamic acid use in benign prostatic hyperplasia surgery

2013-004320-11Phase 4Active

Sponsor
CARLOS SANTOS VILLAR
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tranexamic acid in benign prostatic hyperplasia (BPH), sponsored by CARLOS SANTOS VILLAR. Primary endpoints: Perioperative hemoglobin levels, Perioperative hematocrit levels and 3 more. Started Mar 2014; status: active.

02

Drugs

tranexamic acid
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on 2013-004320-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004320-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call